Sign in
4

Changes in Ownership

Outlook Therapeutics, Inc. Filed Acc 0001209191-19-006603

Director bought 19,390 shares at an average $0.75 ($14,560)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
HILZINGER KURT J Director 2019-01-30 Purchase +4,890 $0.72 $3,521 164,464 D: show line 1 in the form
HILZINGER KURT J Director 2019-01-31 Purchase +6,300 $0.75 $4,725 170,764 D: show line 2 in the form
HILZINGER KURT J Director 2019-02-01 Purchase +8,200 $0.77 $6,314 178,964 D: show line 3 in the form
Open-market purchases · 19,390 sh · avg $0.75 · $14,560
Loading xslF345X03/doc4.xml…